Najjam serves as Chief Financial Officer (CFO) for Scilex and Sorrento Therapeutics, Inc. leading the functions of Finance, Accounting, and Tax and has over 17 years of experience. Prior to joining Scilex, he worked at NuVasive, Inc. leading various accounting and finance functions. He was instrumental in several acquisitions to build upon NuVasive’s portfolio of products, segments, geographic expansion, and helped the Company achieve its goal of more than $1 billion revenue. He started his career with PricewaterhouseCoopers, where he served various S&P 100 and S&P 500 clients in North America and Asia in the audit and assurance practice. Najjam holds a Bachelor of Arts degree.